Accelerate Diagnostics, Inc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Net sales
Cost of sales:
Cost of sales of products and services
Inventory write-down
Total cost of sales
Gross profit
Costs and expenses:
Research and development
Sales, general and administrative
Total costs and expenses
Loss from operations
Other (expense) income:
Interest expense related-party
Interest expense
Nonrelated Party
Related Party
Total interest expense
Interest expense
Nonrelated Party
Related Party
Loss on extinguishment of debt
Nonrelated Party
Related Party
Total loss on extinguishment of debt
Gain on extinguishment of accounts payable
(Loss) gain on fair value adjustment
Foreign currency exchange (loss) gain
Interest income
Other expense, net
Other (expense) income, net
Total other expense, net
Net loss before income taxes
(Provision) benefit for income taxes
Net loss
Basic and diluted net loss per share (dollars per share)
Net unrealized gain on available-for-sale investments
Foreign currency translation adjustment
Comprehensive loss
Basic net loss per share (in dollars per share)
Diluted net loss per share ( in dollars per share)
Weighted average shares outstanding, basic (in shares)
Weighted average shares outstanding, diluted (in shares)

Comments